8 recruiting, 2 completed, 2 not yet recruiting, 1 active not recruiting. 5 Not applicable, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 3, Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Inflamatory Bowel Disease: new trials by email Literature Review of Inflamatory Bowel Disease trials Research Report on Inflamatory Bowel Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Screening Questionnaires and Musculoskeletal Ultrasound for Early Detection of Spondyloarthritis in IBD Patients DETAIL .IBIS_Q . MSUS - Inflamatory Bowel Disease, Spondylarthritis | Not yet recruiting | Assiut University | 200 | 2026-09-01 | 2026-07-23 | |
| Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease Probiotic Formula, Observation - Inflamatory Bowel Disease | Not applicable | Recruiting | Insel Gruppe AG, University Hospital Bern | 40 | 2026-05-01 | 2026-06-30 |
| Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease Physical Activity Intervention - Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis), Inflamatory Bowel Disease | Not applicable | Active not recruiting | Universidad Complutense de Madrid | 100 | 2026-04-01 | 2026-09-03 |
| Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients injection of CNK-UT009 - Inflamatory Bowel Disease, Crohn Disease (CD) | Phase 1 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2026-04-01 | 2026-02-18 |
| 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease Ga68-FAPI-46 - Crohn's Disease, Intestinal Fibrosis | Early Phase 1 | Recruiting | Mayo Clinic | 45 | 2026-01-26 | 2026-02-09 |
| Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease Infliximab, Adalimumab, Vedolizumab - Inflamatory Bowel Disease, Crohn Disease (CD) | Recruiting | Shanghai 10th People's Hospital | 198 | 2026-01-16 | 2026-07-10 | |
| A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD) guselkumab (GUS), JAK inhibitors (such as upadacitinib/tofacitinib) - Inflamatory Bowel Disease | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 80 | 2026-01-07 | 2026-03-23 | |
| Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease anti-cytokine antibodies, anti-integrin antibodies - Inflamatory Bowel Disease | Recruiting | Peking University First Hospital | 200 | 2025-08-15 | 2025-09-18 | |
| A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab Observation - Inflamatory Bowel Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2025-02-10 | 2026-03-23 | |
| Non-nutritive Sweeteners in Inflammatory Bowel Disease Sucralose (non-nutritive sweetener) - Inflamatory Bowel Disease, Crohn Disease (CD) | Not applicable | Recruiting | University Hospitals Cleveland Medical Center | 40 | 2025-02-03 | 2026-09-25 |
| A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant liposomal curcumin, Liposomal Curcumin - Inflamatory Bowel Disease | Not applicable | Completed | S.LAB (SOLOWAYS) | 40 | 2024-05-05 | 2025-04-11 |
| Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease Sucralose (non-nutritive sweetener) - Inflamatory Bowel Disease, Crohn Disease (CD) | Not applicable | Recruiting | Case Western Reserve University | 40 | 2024-04-18 | 2026-10-01 |
| Clinical Characteristics, Treatment Patterns, and Outcomes of Hospitalized Patients With Refractory Inflammatory Bowel Disease Retrospective medical record review - Inflamatory Bowel Disease | Completed | Shanghai 10th People's Hospital | 1048 | 2020-01-01 | 2026-08-07 |
Crohn Disease (5) · Inflammatory Bowel Diseases (4) · Colitis, Ulcerative (3) · Inflammation (1) · Recurrence (1) · Spondylarthritis (1)
Digestive System Diseases (9) · Gastroenteritis (9) · Gastrointestinal Diseases (9) · Intestinal Diseases (9) · Inflammatory Bowel Diseases (5) · Colitis (3) · Colonic Diseases (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arthritis (1) · Bone Diseases (1) · Disease Attributes (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Spinal Diseases (1)
Observation (2) · trichlorosucrose (2) · Adalimumab (1) · Infliximab (1) · Janus Kinase Inhibitors (1) · Ustekinumab (1) · guselkumab (1) · tofacitinib (1) · upadacitinib (1) · vedolizumab (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · Shanghai 10th People's Hospital (2) · Assiut University (1) · Case Western Reserve University (1) · Insel Gruppe AG, University Hospital Bern (1) · Mayo Clinic (1) · Peking University First Hospital (1) · S.LAB (SOLOWAYS) (1) · Universidad Complutense de Madrid (1) · University Hospitals Cleveland Medical Center (1)
China (5) · United States (3) · Egypt (1) · Russia (1) · Spain (1) · Switzerland (1)
Abigail Raffner, RD PhD (1) · Abigal Raffner, PhD, RD (1) · Christiane Sokollik, Prof (1) · David J Bartlett (1) · Fabio Cominelli, MD PhD (1) · Fabio Cominelli, MD, PhD (1) · Laura Palomino (1)